Digital Balance Biomarkers and Interpretable Evaluation of Disease Severity in Spinocerebellar Ataxia Type 3
Annals of the New York Academy of Sciences · 2026
DOI: 10.1111/nyas.70398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the New York Academy of Sciences, 2026. Verfasst von Yue Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Mechanical Engineering and Automation, Fuzhou University, Fuzhou, China. Hauptthemen laut MEDLINE: Machado-Joseph Disease, Postural Balance. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province of China.
Abstract (Originalsprache)
The clinical assessment of spinocerebellar ataxia type 3 (SCA3) is hindered by subjective factors and inter‐rater variability. This study utilizes a previously validated wearable plantar pressure insole system established in our prior work to build a multiscenario digital balance detection framework, and assesses its efficacy in differentiating SCA3 patients from healthy individuals and in evaluating disease severity. The study involved 74 SCA3 patients and 45 healthy controls, who were equipped with custom‐developed plantar force sensors to perform standing tasks with eyes open (EO) and eyes closed (EC). Center of pressure (COP) variables were analyzed to determine their correlation with clinical characteristics and their discriminative capability. An XGBoost model was employed to classify disease severity, with SHAP analysis providing enhanced interpretability. COP variables derived from EC tasks demonstrated superior performance in terms of area under the curve, accuracy, sensitivity, and specificity compared to those from EO tasks. Significant correlations were identified between COP variables, such as the eyes closed, left side sway velocity (EC‐L velocity) SD, and clinical scores ( r > 0.4). The model achieved an accuracy of 87% in classifying disease severity, with SHAP analysis highlighting key variables and interactions. COP variables offer a robust, multidimensional measure of motor dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Mechanical Engineering and Automation, Fuzhou University, Fuzhou, China.
- Fujian Engineering Research Center of Joint Intelligent Medical Engineering, Fuzhou, China.
- Department of Rehabilitation Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
- Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China.
- National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
ORCID-Profile: Yue Zhang, Yuanyuan Xiao, Wei Lin, Xia Liu, Shi-Rui Gan, Xin-Yuan Chen
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province of China
Zitieren
APA
Zhang, Y., Xiao, Y., Luo, K. L., Lin, W., Zhang, W., Liu, X., Sun, Q. K., Yuan, R. Y., Ni, J., Gan, S. R., & Chen, X. Y. (2026). Digital Balance Biomarkers and Interpretable Evaluation of Disease Severity in Spinocerebellar Ataxia Type 3. Annals of the New York Academy of Sciences. https://doi.org/10.1111/nyas.70398
Vancouver
Zhang Y, Xiao Y, Luo KL, Lin W, Zhang W, Liu X, et al. Digital Balance Biomarkers and Interpretable Evaluation of Disease Severity in Spinocerebellar Ataxia Type 3. Annals of the New York Academy of Sciences. 2026. doi:10.1111/nyas.70398
BibTeX
@article{Zhang2026,
author = {Zhang, Yue and Xiao, Yuanyuan and Luo, Kai-Liang and Lin, Wei and Zhang, Wanli and Liu, Xia and Sun, Qi-Kui and Yuan, Ru-Ying and Ni, Jun and Gan, Shi-Rui and Chen, Xin-Yuan},
title = {Digital Balance Biomarkers and Interpretable Evaluation of Disease Severity in Spinocerebellar Ataxia Type 3},
journal = {Annals of the New York Academy of Sciences},
year = {2026},
doi = {10.1111/nyas.70398}
}
EUVIMED